Jin Medical International annual r&d spending
2021
2022
2023
2024
2025
Jin Medical International R&D Spending Growth & History (ZJYL)
Jin Medical International's r&d spending was $1.6M for fiscal 2025.
View full Jin Medical International company overviewJin Medical International annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-09-30 | $1.6M | $60,378 | +4.03% |
| 2024 | 2024-09-30 | $1.5M | −$45,569 | −2.95% |
| 2023 | 2023-09-30 | $1.5M | −$349,638 | −18.47% |
| 2022 | 2022-09-30 | $1.9M | $325,672 | +20.79% |
| 2021 | 2021-09-30 | $1.6M | — | — |
Jin Medical International r&d spending trends
Between the periods ended 2021-09-30 and 2025-09-30, Jin Medical International's r&d spending decreased from $1.6M to $1.6M, a change of −$9,157.
About the metric
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
Calculation and source
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Jin Medical International source filings ↗